nivolumab
bms
[]
. s gastrointestinal oncology program present hcrn gi16-288: a phase ii trial of perioperative cv301 vaccination in combination with nivolumab and systemic chemotherapy for resectable hepatic-limit... #gi23 
Rutgers Cancer Institute of New Jersey is the state’s only NCI-designated Comprehensive Cancer Center and a leader in patient care and cancer research.